Why a human-LLM collaborative approach matters Systematic reviews in precision oncology require screening thousands of articles to identify randomized controlled trials (RCTs) that illuminate biomarker-driven therapies and targeted interventions. Manual screening, while thorough, is time-consuming and resource-intensive. Large language models (LLMs) can accelerate triage by quickly categorizing relevance and extracting key trial details, but their…